| Outgoing Relation(s) |
| agonist (CHEBI:48705) is a pharmacological role (CHEBI:52210) |
| Incoming Relation(s) |
| AMCR277A (CHEBI:139026) has role agonist (CHEBI:48705) |
| bucladesine (CHEBI:50095) has role agonist (CHEBI:48705) |
| NSC294149 (CHEBI:232978) has role agonist (CHEBI:48705) |
| β-alanine (CHEBI:16958) has role agonist (CHEBI:48705) |
| 5-hydroxytryptamine 2A receptor agonist (CHEBI:145982) is a agonist (CHEBI:48705) |
| 5-hydroxytryptamine 2B receptor agonist (CHEBI:142184) is a agonist (CHEBI:48705) |
| 5-hydroxytryptamine 2C receptor agonist (CHEBI:142185) is a agonist (CHEBI:48705) |
| abscisic acid receptor agonist (CHEBI:73191) is a agonist (CHEBI:48705) |
| adenosine receptor agonist (CHEBI:73311) is a agonist (CHEBI:48705) |
| adenylate cyclase agonist (CHEBI:78548) is a agonist (CHEBI:48705) |
| AMPA receptor agonist (CHEBI:64102) is a agonist (CHEBI:48705) |
| androstane receptor agonist (CHEBI:77326) is a agonist (CHEBI:48705) |
| aryl hydrocarbon receptor agonist (CHEBI:72768) is a agonist (CHEBI:48705) |
| bradykinin receptor agonist (CHEBI:77495) is a agonist (CHEBI:48705) |
| cannabinoid receptor agonist (CHEBI:67072) is a agonist (CHEBI:48705) |
| capsaicin receptor agonist (CHEBI:137401) is a agonist (CHEBI:48705) |
| elastin-laminin receptor agonist (CHEBI:91139) is a agonist (CHEBI:48705) |
| erythropeotin receptor agonist (CHEBI:66894) is a agonist (CHEBI:48705) |
| estrogen receptor agonist (CHEBI:63951) is a agonist (CHEBI:48705) |
| farnesoid X receptor agonist (CHEBI:132972) is a agonist (CHEBI:48705) |
| formyl peptide receptor agonist (CHEBI:131495) is a agonist (CHEBI:48705) |
| G-protein-coupled receptor agonist (CHEBI:70998) is a agonist (CHEBI:48705) |
| glucagon-like peptide-2 receptor agonist (CHEBI:72311) is a agonist (CHEBI:48705) |
| glucocorticoid receptor agonist (CHEBI:63562) is a agonist (CHEBI:48705) |
| glycine receptor agonist (CHEBI:64589) is a agonist (CHEBI:48705) |
| guanylate cyclase 2C agonist (CHEBI:68553) is a agonist (CHEBI:48705) |
| hormone (CHEBI:24621) is a agonist (CHEBI:48705) |
| hormone agonist (CHEBI:51060) is a agonist (CHEBI:48705) |
| insulin-sensitizing drug (CHEBI:50864) is a agonist (CHEBI:48705) |
| IP3 receptor agonist (CHEBI:139109) is a agonist (CHEBI:48705) |
| K-ATP channel agonist (CHEBI:64338) is a agonist (CHEBI:48705) |
| kisspeptin receptor agonist (CHEBI:141001) is a agonist (CHEBI:48705) |
| liver X receptor agonist (CHEBI:86029) is a agonist (CHEBI:48705) |
| LRH-1 agonist (CHEBI:65254) is a agonist (CHEBI:48705) |
| lysophosphatidic acid receptor 3 agonist (CHEBI:139584) is a agonist (CHEBI:48705) |
| MAIT cell agonist (CHEBI:156211) is a agonist (CHEBI:48705) |
| melatonin receptor agonist (CHEBI:79046) is a agonist (CHEBI:48705) |
| metabotropic glutamate receptor agonist (CHEBI:61966) is a agonist (CHEBI:48705) |
| neurokinin-1 receptor agonist (CHEBI:194137) is a agonist (CHEBI:48705) |
| neuropeptide FF receptor agonist (CHEBI:141000) is a agonist (CHEBI:48705) |
| neuropeptide Y2 receptor agonist (CHEBI:138168) is a agonist (CHEBI:48705) |
| NOD1 agonist (CHEBI:194467) is a agonist (CHEBI:48705) |
| odorant receptor agonist (CHEBI:62873) is a agonist (CHEBI:48705) |
| opioid receptor agonist (CHEBI:60606) is a agonist (CHEBI:48705) |
| P2Y2 receptor agonist (CHEBI:53142) is a agonist (CHEBI:48705) |
| piezo1 agonist (CHEBI:194154) is a agonist (CHEBI:48705) |
| platelet-activating factor receptor agonist (CHEBI:75414) is a agonist (CHEBI:48705) |
| PPARα agonist (CHEBI:70782) is a agonist (CHEBI:48705) |
| PPARβ/δ agonist (CHEBI:73730) is a agonist (CHEBI:48705) |
| PPARγ agonist (CHEBI:71554) is a agonist (CHEBI:48705) |
| pregnane X receptor agonist (CHEBI:77318) is a agonist (CHEBI:48705) |
| prostacyclin receptor agonist (CHEBI:90845) is a agonist (CHEBI:48705) |
| prostaglandin receptor agonist (CHEBI:66900) is a agonist (CHEBI:48705) |
| protein kinase agonist (CHEBI:64106) is a agonist (CHEBI:48705) |
| retinoic acid receptor agonist (CHEBI:67198) is a agonist (CHEBI:48705) |
| retinoid X receptor agonist (CHEBI:63794) is a agonist (CHEBI:48705) |
| SMO receptor agonist (CHEBI:131809) is a agonist (CHEBI:48705) |
| sphingosine-1-phosphate receptor agonist (CHEBI:63114) is a agonist (CHEBI:48705) |
| thrombopoietin receptor agonist (CHEBI:85012) is a agonist (CHEBI:48705) |
| thromboxane A2 agonist (CHEBI:139044) is a agonist (CHEBI:48705) |
| Toll-like receptor 2 agonist (CHEBI:77161) is a agonist (CHEBI:48705) |
| Toll-like receptor 7 agonist (CHEBI:234474) is a agonist (CHEBI:48705) |
| tropomyosin-related kinase B receptor agonist (CHEBI:140489) is a agonist (CHEBI:48705) |
| TRPA1 channel agonist (CHEBI:137514) is a agonist (CHEBI:48705) |
| TRPV1 agonist (CHEBI:140535) is a agonist (CHEBI:48705) |
| TRPV4 agonist (CHEBI:140061) is a agonist (CHEBI:48705) |
| vitamin D receptor agonist (CHEBI:139503) is a agonist (CHEBI:48705) |
